| Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961 EH Panosyan, NL Seibel, S Martin-Aragon, PS Gaynon, IA Avramis, ... Journal of pediatric hematology/oncology 26 (4), 217-226, 2004 | 261 | 2004 |
| Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells K Jiménez-Aliaga, P Bermejo-Bescós, J Benedí, S Martín-Aragón Life sciences 89 (25-26), 939-945, 2011 | 253 | 2011 |
| Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease P Bermejo, S Martín-Aragón, J Benedí, C Susín, E Felici, P Gil, JM Ribera, ... Immunology letters 117 (2), 198-202, 2008 | 226 | 2008 |
| Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment P Bermejo, S Martín-Aragón, J Benedí, C Susín, E Felici, P Gil, ... Free radical research 42 (2), 162-170, 2008 | 183 | 2008 |
| Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damagein rats and primary cultures of rat hepatocytes S Martin-Aragon, B De Las Heras, MI Sanchez-Reus, J Benedi Experimental and Toxicologic Pathology 53 (2-3), 199-206, 2001 | 151 | 2001 |
| Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells J Benedı́, R Arroyo, C Romero, S Martı́n-Aragón, AM Villar Life sciences 75 (10), 1263-1276, 2004 | 145 | 2004 |
| Prevalence and determinants of self-medication practice among selected households in Addis Ababa community M Shafie, M Eyasu, K Muzeyin, Y Worku, S Martín-Aragón PloS one 13 (3), e0194122, 2018 | 126 | 2018 |
| Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment S MARTÍN‐ARAGÓN, JM Benedí, AM Villar Journal of pharmacy and pharmacology 49 (1), 49-52, 1997 | 91 | 1997 |
| Effects of the antioxidant (6, 7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice S Martín-Aragón, JM Benedí, AM Villar Gerontology 44 (1), 21-25, 1998 | 83 | 1998 |
| Antioxidant action of Vaccinium myrtillus L. S Martín‐Aragón, B Basabe, JM Benedí, AM Villar Phytotherapy Research: An International Journal Devoted to Pharmacological …, 1998 | 70 | 1998 |
| Determination of malonaldehyde in Alzheimer’s disease: a comparative study of high-performance liquid chromatography and thiobarbituric acid test P Bermejo, P Gomez-Serranillos, J Santos, E Pastor, P Gil, ... Gerontology 43 (4), 218-222, 1997 | 60 | 1997 |
| In vitro antiamyloidogenic properties of 1, 4-naphthoquinones P Bermejo-Bescós, S Martín-Aragón, KL Jiménez-Aliaga, A Ortega, ... Biochemical and biophysical research communications 400 (1), 169-174, 2010 | 59 | 2010 |
| Metalloproteinase’s activity and oxidative stress in mild cognitive impairment and Alzheimer’s disease S Martín-Aragón, P Bermejo-Bescós, J Benedí, E Felici, P Gil, JM Ribera, ... Neurochemical research 34, 373-378, 2009 | 53 | 2009 |
| Biomarkers of sarcopenia in very old patients with hip fracture C Sánchez‐Castellano, S Martín‐Aragón, P Bermejo‐Bescós, ... Journal of Cachexia, Sarcopenia and Muscle 11 (2), 478-486, 2020 | 45 | 2020 |
| Several targets involved in Alzheimer’s disease amyloidogenesis are affected by morin and isoquercitrin V Carmona, S Martín-Aragón, J Goldberg, D Schubert, P Bermejo-Bescós Nutritional neuroscience 23 (8), 575-590, 2020 | 44 | 2020 |
| Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils A Ortega, Á Rincón, KL Jiménez-Aliaga, P Bermejo-Bescós, ... Bioorganic & medicinal chemistry letters 21 (8), 2183-2187, 2011 | 44 | 2011 |
| La nutrición del adolescente: hábitos saludables S Martín-Aragón, HM Pasero Farmacia profesional 22 (10), 42-47, 2008 | 33 | 2008 |
| Children’s Cancer Group Study CCG-1961. Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children’s Cancer Group Study … EH Panosyan, NL Seibel, S Martin-Aragon, PS Gaynon, IA Avramis, ... J Pediatr Hematol Oncol 26 (4), 217-226, 2004 | 33 | 2004 |
| Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI) P Bermejo-Bescós, S Martín-Aragón, K Jiménez-Aliaga, J Benedí, E Felici, ... Neurochemical research 38, 1415-1423, 2013 | 32 | 2013 |
| Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase … VI Avramis, S Martin-Aragon, EV Avramis, BL Asselin Anticancer research 27 (4C), 2561-2572, 2007 | 32 | 2007 |
